Introduction
============

Numerous large-scale clinical studies have suggested that hypertension is a risk factor for cardiovascular diseases ([@b1-mmr-14-01-0776]--[@b3-mmr-14-01-0776]). High blood pressure promotes the development of cardiovascular diseases via various pathological processes, including endothelial dysfunction ([@b4-mmr-14-01-0776]), inflammation ([@b5-mmr-14-01-0776]) and myocardial fibrosis ([@b5-mmr-14-01-0776],[@b6-mmr-14-01-0776]). Though the pathogenesis of myocardial fibrosis in hypertension has previously been heavily investigated, the mechanism remains to be fully elucidated.

Periostin is a 90-kDa secretory protein that was previously demonstrated to be secreted from a mouse osteoblastic cell line ([@b7-mmr-14-01-0776]). As an extracellular matrix (ECM) protein, periostin is prominently expressed during tissue fibrosis in the kidney ([@b8-mmr-14-01-0776]--[@b10-mmr-14-01-0776]), lung ([@b11-mmr-14-01-0776],[@b12-mmr-14-01-0776]) and heart ([@b13-mmr-14-01-0776],[@b14-mmr-14-01-0776]). The heart ventricles are rich in ECM secreted by fibroblasts, thus, it has been hypothesized that periostin is involved in hypertension-induced myocardial fibrosis.

Previous studies indicate that oxidative stress is involved in the development of hypertension-induced myocardial fibrosis ([@b15-mmr-14-01-0776]--[@b17-mmr-14-01-0776]), however, the exact mechanisms by which oxidative stress induces interstitial fibrosis remain to be elucidated. Multiple lines of evidence have indicated that oxidative stress accelerates fibrosis via regulation of profibrotic factors and ECM, thus, the present study hypothesizes that oxidative stress may contribute to periostin expression. The present study aimed to determine the effect of periostin in myocardial fibrosis in an experimental hypertensive rat model and to investigate the underlying molecular mechanisms.

Materials and methods
=====================

Experimental animals and treatment
----------------------------------

The experimental and feeding protocols were approved by the Ethics Committee of Drum Tower Hospital (Nanjing, China). Rats (4 weeks old, male, n=16; weight, 90--115 g) were housed together in an animal room at 22°C, normal atmosphere and 12 h light/dark cycles, with free access to normal drinking water and fed chow with 0.4% NaCl (normal group; n=8) or 8% NaCl (hypertension group; n=8) for 36 weeks. At the end of the study, the rats were anesthetized with 3% isoflurane and 8 hearts from each group were rapidly excised and divided into three parts. Cardiac fibroblasts used in present study were isolated from another 10 normal rats. Physiological parameters, including blood pressure and heart rate, were monitored every 4 weeks (BP-2006A; Softron, Tokyo, Japan) until the animals were sacrificed.

Dihydroethidium (DHE) staining and Masson\'s staining
-----------------------------------------------------

At the endpoint of the experiment, the hearts were rapidly excised from the rats and were divided into three parts. One part was treated routinely and the others were flash frozen. The tissue was fixed and embedded with optimal cutting temperature compound (Department of Pathology, Drum Tower Hospital, Nanjing. China), and was subsequently cut into 5 *μ*m sections. The frozen heart sections were then incubated with 4 *μ*m/ml DHE dye (Beyotime Institute of Biotechnology, Haimen, China) for 30 min at 37°C. Oxidative stress was indicated by red staining and visualized using a fluorescence microscope. Image Pro Plus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA) was used to quantify the red staining in three randomly selected fields in each section (n=16). The second part of the tissue samples were fixed with 4% paraformaldehyde, embedded in wax and cut into 5-*μ*m sections. Masson\'s staining was used to assess myocardial fibrosis. Collagen volume fraction was analyzed using Image Pro Plus 6.0 software to quantify the collagen deposition in the heart tissue. The remaining tissue was used for western blot analysis.

Isolation of fibroblasts
------------------------

Cardiac fibroblasts were isolated from adult rats as previously described ([@b18-mmr-14-01-0776]). Briefly, following anesthesia with 3% isoflurane of the rats, the hearts were rapidly excised, rinsed and homogenized in cold phosphate-buffered saline (PBS). Then, the tissues were digested in Dulbecco\'s modified Eagle\'s medium (DMEM; Hyclone, Logan, TX, USA) containing 0.1% collagenase type II (Nanjing SunShine Biotechnology Co., Ltd., Nanjing, China) at 37°C. The resulting supernatant was centrifuged at 36°C for 30 min at 500 × g and resuspended, prior to seeding in DMEM containing 10% fetal bovine serum (Hyclone). After 1 h, the supernatant was removed and the adherent cells were maintained as cardiac fibroblasts. Unless otherwise stated, cardiac fibroblasts at passage 1 to 3, cultured at 37°C and 5% CO~2~, were used in the present study and were serum-starved overnight prior to treatments with Ang II (1, 2 or 4 *μ*M; Sigma-Aldrich, St. Louis, MO, USA) or NAC (5 or 10 nM; Beyotime Institute of Biotechnology, Haimen, China) for 24 h.

Immunofluorescence for α-smooth muscle actin (α-SMA)
----------------------------------------------------

When adherent cells reached 80--90% confluency, they were seeded in 24-well plates. Following treatment with Ang II (4 *μ*M) or NAC (10 nM) for 24 h, the fibroblasts were washed with PBS 3 times and fixed with 4% paraformaldehyde for 60 min at room temperature. After blocking with 2% BSA at room temperature for 1 h, the cells were incubated with rabbit anti-α-SMA primary antibody (cat. no. ab5694; 1:100; Abcam, Cambridge, UK). Following two washes with PBS, the cells were incubated with Alexa Fluor^®^ 594-conjugated goat anti-rabbit secondary antibody (cat. no. A-11037; 1:400; Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 1 h under dark conditions at room temperature. Finally, the cells were counterstained with 4′,6-diamidino-2-phenylindole (Sigma-Aldrich, St. Louis, MO, USA) for 10 min, and then visualized using a confocal laser scanning microscope.

Measurement of intracellular reactive oxygen species (ROS) in fibroblasts
-------------------------------------------------------------------------

Intracellular ROS generation was detected using the fluorescent probe 2′,7′-dichlorofluorescin diacetate (DCFH). Briefly, fibroblasts were plated in 24-well plates. Following treatment with Ang II or NAC, the medium was removed and the cells were washed with PBS. A solution of 5 *μ*M DCFH probe in serum-free DMEM was then added to the cells for 30 min at 37°C. The plates were washed twice and the intracellular ROS levels were detected by microscope.

Western blotting
----------------

Tissue or treated cells were homogenized in lysis buffer containing a 1:100 dilution of protease inhibitor (Sigma-Aldrich). The lysates were centrifuged at 13,800 × g for 10 min and proteins were harvested from the supernatants. Protein concentration was detected using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL, USA). Equal quantities of proteins (30 *μ*g) were separated by 10% SDS-PAGE and electroblotted to polyvinylidene fluoride membranes. Following blocking with 5% milk, the membranes were incubated with primary antibodies overnight at 4°C. The membranes were washed with Tris-buffered saline containing 0.1% Tween 20 then incubated with secondary antibody (cat. no. sc-2004; 1:10,000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) for 2 h at room temperature. Proteins were detected using enhanced chemiluminescence reagents (Pierce) and images were obtained by exposure to films. The densities of each band were analyzed using Bio-Rad Quantity One v4.62 imaging software (Bio-Rad Laboratories, Inc., Hercules, CA USA). The results are presented as a percentage change compared with that in controls following normalization to the β-actin bands for each sample. The following antibodies were used: Anti-α-SMA (cat. no. ab5654; 1:1,000; Abcam); anti-β-actin (cat. no. sc-130657; 1:2,000; Santa Cruz Biotechnology, Inc.), anti-periostin (cat. no. sc-67233; 1:500; Santa Cruz Biotechnology, Inc.), anti-p47phox (cat. no. A1148; 1:1,000; ABclonal Biotech Co., Ltd., Cambridge, MA, USA), anti-gp91phox (cat. no. sc-20782; 1:1,000; Santa Cruz Biotechnology, Inc.), and anti-p66shc (cat. no. sc-1695; 1:1,000; Santa Cruz). All blots were performed on three independent occasions.

Statistical analysis
--------------------

Analyses were performed using SPSS software (version 21.0; IBM SPSS, Armonk, NY, USA). Differences between 2 groups were analyzed by Student\'s t-test and one-way analysis of variance was used to test significance for \>2 groups. Student-Neuman-Keuls or Dunnett\'s T3 tests were used for post-hoc multiple comparisons. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Blood pressure increased in high-salt induced hypertensive rats
---------------------------------------------------------------

As a high salt diet is an important risk factor in hypertension, an *in vivo* hypertension model was produced with a sustained high salt diet for 36 weeks. At the end of the experimental period, blood pressure levels and heart rate of the animals were measured. Compared with the normal rats (0.4% NaCl diet), systolic blood pressure (P\<0.01; [Fig. 1A](#f1-mmr-14-01-0776){ref-type="fig"}), diastolic blood pressure (P\<0.05; [Fig. 1B](#f1-mmr-14-01-0776){ref-type="fig"}) and mean blood pressure (P\<0.05; [Fig. 1C](#f1-mmr-14-01-0776){ref-type="fig"}) were significantly increased in the high salt (8% NaCl diet)-induced hypertensive rats. At week 36, no significant differences in heart rate were observed between the 2 groups ([Fig. 1D](#f1-mmr-14-01-0776){ref-type="fig"}).

Periostin is upregulated and myocardial fibrosis observed in hypertensive rats
------------------------------------------------------------------------------

Periostin has previously been considered to be an important mediator of fibrosis, thus, western blotting was performed to detect the expression levels of periostin in the hearts of the 2 groups. As demonstrated in [Fig. 2A](#f2-mmr-14-01-0776){ref-type="fig"}, the protein expression levels of periostin in hypertensive hearts was significantly upregulated compared with normal hearts (P\<0.05). Histological observations following Masson\'s trichrome staining indicated that myocardial fibrosis was induced in hypertensive rats compared with normal rats (P\<0.05; [Fig. 2B](#f2-mmr-14-01-0776){ref-type="fig"}).

Oxidative stress is increased in hypertensive hearts
----------------------------------------------------

To investigate the role of oxidative stress in hypertensive fibrosis, ROS production was measured in samples from normal and hypertensive rats. As demonstrated in [Fig. 3A](#f3-mmr-14-01-0776){ref-type="fig"}, oxidative stress, indicated by DHE staining, was significantly increased in hypertensive hearts compared with normal hearts (P\<0.05; [Fig. 3A](#f3-mmr-14-01-0776){ref-type="fig"}). Furthermore, to evaluate the increased oxidative stress in hypertensive hearts, the expression levels of oxidative stress-associated proteins were determined. Western blotting demonstrated that the protein expression level of gp91phox (P\<0.01), p47phox (P\<0.05) and p66shc (P\<0.05) were significantly increased in the hearts of hypertensive rats compared with normal rats ([Fig. 3B](#f3-mmr-14-01-0776){ref-type="fig"}). These proteins all contribute to oxidative stress.

Angiotensin II (Ang II) increases expression of periostin and α-SMA in cardiac fibroblasts via oxidative stress
---------------------------------------------------------------------------------------------------------------

Ang II is important for the initiation of myocardial fibrosis, thus, *in vitro* studies using Ang II to treat cardiac fibroblasts were performed to investigate oxidative stress and periostin expression levels in hypertensive fibrosis. As demonstrated in [Fig. 4A](#f4-mmr-14-01-0776){ref-type="fig"}, compared with the control group, incubation of fibroblasts with Ang II significantly upregulated the expression of periostin (P\<0.01), whereas the expression was suppressed by pretreating with N-acetyl-L-cysteine (NAC), an inhibitor of ROS (P\<0.01 and P\<0.05 for 5 and 10 nM NAC, respectively). The anti-oxidative effect of NAC was demonstrated using a DCFH probe, which indicated that NAC attenuated Ang II-induced ROS production in fibroblasts ([Fig. 4B](#f4-mmr-14-01-0776){ref-type="fig"}). To investigate the association between periostin and the differentiation of fibroblasts, the expression of α-SMA was detected. Western blot analysis ([Fig. 4C](#f4-mmr-14-01-0776){ref-type="fig"}) and immunofluorescence ([Fig. 4D](#f4-mmr-14-01-0776){ref-type="fig"}) demonstrated that the increased expression levels of α-SMA induced by Ang II compared with control, was abrogated by NAC treatment (P\<0.01).

Discussion
==========

The current study demonstrated the contribution of oxidative stress-induced periostin to the development of myocardial fibrosis in hypertension.

Hypertensive myocardial fibrosis contributing to myocardial remodeling is the pathophysiological basis of hypertension and eventually results in heart failure. Myocardial fibrosis is considered to be an early event of heart failure by reducing contractile efficiency and demanding greater cardiac contractile force. Fibrosis is a complex condition mediated by profibrotic factors, an imbalance of collagen synthesis and degradation, upregulation of ECM and increased oxidative stress. The present study focused on ECM and oxidative stress in hypertensive hearts.

Increased periostin and oxidative stress in hypertensive rats
-------------------------------------------------------------

Periostin, a member of the fasciclin family, is an ECM protein that promotes progression of fibrosis via regulating ECM homeostasis ([@b19-mmr-14-01-0776],[@b20-mmr-14-01-0776]). Periostin was previously demonstrated to be upregulated in numerous heart diseases. A previous study by Zhao *et al* ([@b14-mmr-14-01-0776]) demonstrated that periostin expression was upregulated and associated with myocardial fibrosis in human failing hearts. Another investigation in mice following transverse aortic constriction confirmed the effect of periostin in heart failure ([@b13-mmr-14-01-0776]). Meyer *et al* ([@b21-mmr-14-01-0776]) demonstrated that periostin expression levels as a biomarker associated with ECM remodeling contributing to heart failure were significantly higher in men compared with women. The results of the present study demonstrated that periostin was also increased in hypertensive hearts. This finding is consistent with another investigation that demonstrated that eplerenone enhanced cardioprotective effects in hypertensive heart failure by regulating ECM proteins, including periostin ([@b22-mmr-14-01-0776]). However, to the best of our knowledge, the mechanisms that regulate periostin expression have not been previously investigated.

Oxidative stress
----------------

A major source of ROS in cardiovascular diseases is the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family ([@b17-mmr-14-01-0776]). NADPH oxidase consists of multiple subunits: Membrane-bound proteins (including gp91phox); cytosolic regulation subunits (such as p47phox); and a small GTP-binding protein Rac 1 ([@b23-mmr-14-01-0776]). The current study demonstrated that p47phox and gp91phox were upregulated in hypertensive hearts, which is consistent with the findings of others studies suggesting that NADPH oxidase contributes to kidney and aortic media damage in hypertension ([@b24-mmr-14-01-0776],[@b25-mmr-14-01-0776]).

In addition, p66shc, an isoform of SRC transforming protein 1, has also been recognized as an important mediator in oxidative stress in the cardiovascular system ([@b26-mmr-14-01-0776]--[@b28-mmr-14-01-0776]). Notably, consistent with previous findings ([@b29-mmr-14-01-0776]), the present study demonstrated that p66shc modulates ROS production in hypertension.

Furthermore, DHE staining was also used to evaluate oxidative stress in hypertensive rats. DHE staining further supported the results of ph47phox, gp91phox and p66shc, suggesting that hypertensive hearts exhibited increased oxidative stress compared with normal hearts. Consistently with the findings of the present study, an accumulating body of evidence suggests that oxidative stress is an essential characteristic of hypertension ([@b30-mmr-14-01-0776]--[@b33-mmr-14-01-0776]). Thus, considering the present study and previous findings in hypertension, ROS generation may be important for the development of hypertension.

Ang II increases expression of periostin via oxidative stress
-------------------------------------------------------------

As periostin and oxidative stress were upregulated in hypertension, an *in vitro* experiment to investigate their association was conducted.

A number of studies have demonstrated that Ang II is the most important hormone that regulates myocardial fibrosis ([@b18-mmr-14-01-0776],[@b34-mmr-14-01-0776]), which is supported by previous studies that have demonstrated that Ang II antagonists can prevent fibrosis in various diseases ([@b33-mmr-14-01-0776],[@b35-mmr-14-01-0776]). Ang II promotes systemic arteriole contraction that results in hypertension via binding Ang II type I receptor, and contributes to myofibrosis in hypertension-associated heart diseases. Following stimulation by certain factors, including Ang II, cardiac fibroblasts can differentiate to myofibroblasts, exhibiting increased expression of a number of cytoskeletal protein, including α-SMA and collagen. Differentiation of cardiac fibroblasts into myofibroblasts contributes to cardiac fibrosis and eventually affects the dynamic contractile properties of the heart ([@b36-mmr-14-01-0776]). Thus, the present study performed *in vitro* experiments using cardiac fibroblasts treated with Ang II to investigate the effect of oxidative stress and periostin in hypertensive fibrosis.

The current study demonstrated that Ang II increased the expression of periostin in fibroblasts, which is also supported by the previous finding that periostin was induced by Ang II in cardiac fibroblasts ([@b13-mmr-14-01-0776]). Notably, in the present study, upregu-lation of periostin was accompanied by an increase in ROS generation, while inhibition of ROS blocked the induction of periostin, suggesting that Ang II upregulates the expression of periostin via an oxidative stress-mediated signaling pathway. To the best of our knowledge, this is the first report demonstrating that oxidative stress also regulates periostin expression induced by Ang II.

Consistent with previous findings, the present study demonstrated that Ang II upregulates the expression of α-SMA in fibroblasts by western blot analysis and immunofluores-cence ([@b18-mmr-14-01-0776]), suggesting that Ang II induces differentiation of cardiac fibroblasts into myofibroblasts. Notably, the results indicated that ROS-induced periostin expression may be important for Ang II-induced differentiation of cardiac fibroblasts.

In conclusion, the results of the present study demonstrated that oxidative stress-induced upregulation of periostin may be important for in myocardial fibrosis in hypertensive rats. Therefore, periostin may serve as a potential target for the prevention of hypertension-induced myocardial fibrosis.
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![Evaluation of SBP, DBP, MBP and HR in normal and high-salt induced hypertensive rats. (A) SBP, (B) DBP and (C) MBP measurements in high salt-induced hypertensive and normal rats. (D) HR in normal and hypertensive rats. n=8 per group, ^\*^P\<0.05, ^\*\*^P\<0.01, comparisons indicated by brackets. N, normal rats group; HT, hypertensive rats group; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; HR, heart rate; NS, not significant.](MMR-14-01-0776-g00){#f1-mmr-14-01-0776}

![Expression of periostin and myocardial fibrosis in hypertensive rats. (A) Representative western blot of periostin in normal and hypertensive hearts. (B) Masson staining in heart sections of the two groups; bar=100 *μ*m. ^\*^P\<0.05, comparisons indicated by brackets. N, normal rats group; HT, hypertensive rats group.](MMR-14-01-0776-g01){#f2-mmr-14-01-0776}

![Increased oxidative stress in hypertensive rats. (A) The superoxide level determined by DHE staining in heart sections of the two groups; bar=50 *μ*m. (B) Representative western blot of oxidase levels in normal and hypertensive rats. ^\*^P\<0.05, ^\*\*^P\<0.01, comparisons indicated by brackets. N, normal rats group; HT, hypertensive rats group; DHE, dihydroethidium.](MMR-14-01-0776-g02){#f3-mmr-14-01-0776}

![Periostin was induced by oxidative stress in Ang II-induced differentiation of cardiac fibroblasts. (A) *In vitro* treatment with NAC reduced the expression of perisotin induced by Ang II in cardiac fibroblasts. (B) DCFH staining showed induction of ROS production in Ang II treated fibroblasts, while NAC inhibited ROS genesis. (C) Upregulated expression of α-SMA induced by Ang II was decreased by pretreatment of NAC. (D) NAC was observed to attenuate Ang II-induced expression of α-SMA using immunofluorescence. ^\*\*^P\<0.01 vs. the control group; ^\#^P\<0.05 vs. the Ang II (4 *μ*M) group; ^\#\#^P\<0.01 vs. the Ang II (4 *μ*M) group. Bar=50 *μ*m. Ang II, angiotensin II; NAC, N-acetyl-L-cysteine; DCFH, 2′,7′ dichlorodihydrofluorescin; α-SMA, α-smooth muscle actin; con, control.](MMR-14-01-0776-g03){#f4-mmr-14-01-0776}
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